Peter Ellmark

1.9k citations
51 papers · 1.5k · h-index 20

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • T-cell and B-cell Immunology

Papers in

    • Cancer Immunotherapy and Biomarkers 18
    • Pancreatic and Hepatic Oncology Research 4
    • Immunotherapy and Immune Responses 17
    • T-cell and B-cell Immunology 3

Peter Ellmark

50 papers receiving 1.4k citations

Peers

Peter Ellmark
Comparison fields: 5 of 66
  • Oncology 567
  • Immunology 366
  • Radiology, Nuclear Medicine and Imaging 171
  • Molecular Biology 331
  • Cancer Research 51
Replace Christian M. Capitini with:
Christian M. Capitini United States
Jacqueline Douglass United States
Henry J.M.A.A. Zijlmans Netherlands
Simone Gaedicke Germany
Justin D. Cohen United States
Amer M. Najjar United States
Kirsten Tangemann United States
Shangzi Wang United States
Yuan Cao United States
Łukasz Magiera United Kingdom
Peter Ellmark relative to Christian M. Capitini United States Christian M. Capitini's profile →
Citations per field
00.5×1.5×2.0×
Christian M. Capitini · 1×
Citations per year

Countries citing papers authored by Peter Ellmark

Since Specialization
Citations

This map shows the geographic impact of Peter Ellmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Ellmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Ellmark more than expected).

Fields of papers citing papers by Peter Ellmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Ellmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Ellmark. The network helps show where Peter Ellmark may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Ellmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Ellmark Line = papers co-authored together Peter Ellmark links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008127
2 2008102
3 2019100
4 200696
5 200895
6 201492
7 201387
8 201984
9 201471
10 201664
11 202160
12 200655
13 201640
14 202439
15 202036
16 201730
17 202128
18 201225
19 202224
20 200320

About Peter Ellmark

Peter Ellmark is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Virology, having authored 51 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), Immunotherapy and Immune Responses (17 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Advanced Biosensing Techniques and Applications (9 papers), Pancreatic and Hepatic Oncology Research (4 papers), T-cell and B-cell Immunology (3 papers), HIV Research and Treatment (2 papers) and Chemical Synthesis and Analysis (2 papers). The work is most often cited by research in Oncology (567 citations), Immunology (366 citations), Radiology, Nuclear Medicine and Imaging (171 citations), Molecular Biology (331 citations) and Cancer Research (51 citations). Peter Ellmark has collaborated with scholars based in Sweden, United States and Australia. Frequent co-authors include Carl A.K. Borrebaeck, Thomas H. Tötterman, Sara M. Mangsbo, Christer Wingren, Per Norlén, Christina Furebring, Johan Ingvarsson, Anders Carlsson, Linda C. Sandin and Niina Veitonmäki. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Immunology Immunotherapy, OncoImmunology, PROTEOMICS and Cancer Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact